Viral Defender Inc. Release: Canadians Invent Surgical Mask That Protects Against Airborne Viruses

MONTREAL, CANADA--(Marketwire - May 05, 2009) - Viral Defender Inc. today announced the worldwide launch of Triosyn ® disposable and self decontaminating surgical masks designed to provide increased protection against airborne viruses which includes Swine flu. This innovative respirator is a new and improved disposable facemask with a novel microbial filter that stops airborne diseases and viral threats. The technology, developed by Triosyn Research Laboratories of Quebec, designed to protect individuals against dangerous and deadly diseases in order to preserve health and safety and ensure the continuity of business and essential services in the event of pandemics, bioterrorism and environmental disasters.

The result of more than 15 years of research and development, Viral Defender respirators with patented antimicrobial protection have been proven in extensive laboratory testing to remove 99.99% of organisms from the air. The Triosyn filter has been rigorously tested by the U.S. Air Force, Health Canada, Nelson Laboratories, and other world-renowned third-party research institutions.

Each Viral Defender surgical mask is implanted with a specially-designed filter layer containing Triosyn® resin, a patented technology that is embedded within the fibers of the filter. Triosyn resin provides a unique mechanism of capture that stops microorganisms on contact, providing a safe, clean and unrestricted air flow through the mask filter. Registered with the U.S. Environmental Protection Agency, Triosyn resin greatly enhances the capture performance by increasing the surface area of each filter fiber, while the molecular makeup of the resin expresses an electrochemical charge that pulls microorganisms out of the airflow.

In the event of a global pandemic, the best possible equipment will be essential to protecting our nation's workforce, especially those providing vital protection services, such as first responders, healthcare workers, police and government agencies. The new Viral Defender surgical mask fills a major gap in the need for advanced respiratory protection against viruses and viral pandemics like the Swine flu. No other facemask can provide such a high level of respiratory protection against viral threats."

The inadequacy of current masks in providing protection of airborne viruses was studied by Anna Balazy of the Department of Health-Related Aerosol Studies at the University of Cincinnati. Published in the American Journal of Infection Control (March 2006), Balazy's research found that surgical masks and N95 respirators do not provide adequate protection against viruses, which are smaller than the particles used in N95 certification tests.

The Viral Defender T-5000V, is certified P95 by the U.S. National Institute for Occupational Safety and Health (NIOSH).

A recent research study, audited by Claude Lamarre, researcher at The Pasteur Institute's Department of Microbiology, and published in Urgence Pratique (November 2006) found Triosyn Disposable Respirators provided superior protection to the competitor products tested. This study demonstrated that the respirators have additional viral protection that is 100 times higher than that of masks rated FFP2, a product marking certification under the Personal Protective Equipment Directive in Europe. The study concluded that any masks below Triosyn's level of protection level would be insufficient at protecting against contraction of a pandemic virus.

The Disposable Respirators with antimicrobial protection are currently in use by leading corporations, healthcare institutions, emergency medical services and government agencies, including Chevron North America, FEMA Medical Response Services, New England Emergency Management, Iowa Northland Regional Council, Maine Emergency Management Agency, Avnet, Inc., NW Natural Gas Company, Southern Nevada Health District, and FMS Veteran Affairs. You can visit Viral Defenders website for test results and technical.